Anticoagulants Market Revenue 2025 to 2034
Anticoagulants Market Revenue 2025 to 2034
Anticoagulants Market (By Indication of Disease: Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), Atrial Fibrillation, Heart Attacks, and Others; By Administration Route: Oral and Injectable; By Drug Class: NOACs, Heparin & LMWH, Vitamin K Antagonist, and Others; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, and Others; By Region: North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa) Industry Size, Share, Growth, Trends 2025 to 2034.
Customisation Request
Revenue, 2025
USD 37.08 Bn
Forecast Year, 2034
USD 81.16 Bn
CAGR, 2025 - 2034
9.11%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global anticoagulants market is witnessing strong growth, driven by the rising prevalence of cardiovascular disorders and increasing adoption of advanced blood-thinning therapies. Valued at USD 37.08 billion in 2025, the market is expected to reach approximately USD 81.16 billion by 2034, expanding at a CAGR of 9.11% during the forecast period.
Anticoagulants Market Size Analysis
Anticoagulants Market Size By Indication 2025 to 2034 (USD Billion)
| Indication | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Pulmonary Embolism (PE) | 8.16 | 8.94 | 9.80 | 10.74 | 11.77 | 12.90 | 14.14 | 15.50 | 16.98 | 18.61 |
| Deep Vein Thrombosis (DVT) | 9.27 | 10.07 | 10.95 | 11.90 | 12.93 | 14.05 | 15.27 | 16.59 | 18.02 | 19.59 |
| Atrial Fibrillation | 11.87 | 13.03 | 14.30 | 15.70 | 17.24 | 18.92 | 20.77 | 22.80 | 25.03 | 27.47 |
| Heart Attacks | 4.45 | 4.81 | 5.21 | 5.64 | 6.10 | 6.59 | 7.13 | 7.71 | 8.34 | 9.02 |
| Others | 3.34 | 3.60 | 3.88 | 4.19 | 4.52 | 4.87 | 5.26 | 5.67 | 6.11 | 6.58 |
Anticoagulants Market Size By Administration Route 2025 to 2034 (USD Billion)
| Administration Route | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Oral | 25.21 | 27.63 | 30.28 | 33.19 | 36.37 | 39.85 | 43.67 | 47.85 | 52.44 | 57.46 |
| Injectable | 11.87 | 12.83 | 13.86 | 14.98 | 16.19 | 17.49 | 18.89 | 20.41 | 22.05 | 23.81 |
Anticoagulants Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 15.57 | 16.91 | 18.36 | 19.94 | 21.65 | 23.51 | 25.53 | 27.72 | 30.09 | 32.67 |
| Asia Pacific | 10.38 | 11.49 | 12.71 | 14.06 | 15.56 | 17.20 | 19.02 | 21.03 | 23.24 | 25.68 |
| Europe | 8.16 | 8.86 | 9.62 | 10.45 | 11.35 | 12.33 | 13.39 | 14.54 | 15.79 | 17.15 |
| LAMEA | 2.97 | 3.20 | 3.44 | 3.71 | 3.99 | 4.30 | 4.63 | 4.98 | 5.36 | 5.77 |
Anticoagulants Market Size to Surpass USD 81.16 Billion by 2034
The anticoagulants market size accounted for USD 37.08 billion in 2025 and is predicted to touch around USD 81.16 billion by 2034 at a CAGR of 9.11%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
